Christophe Luhata

ORCID: 0009-0003-3249-2644
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Vaccine Coverage and Hesitancy
  • COVID-19 epidemiological studies
  • Hepatitis B Virus Studies
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS Research and Interventions
  • Poxvirus research and outbreaks
  • Virology and Viral Diseases
  • Hepatitis C virus research
  • Global Maternal and Child Health
  • Viral Infections and Outbreaks Research
  • Reproductive Health and Contraception
  • Healthcare Systems and Reforms
  • Zoonotic diseases and public health
  • Sex work and related issues
  • Emergency and Acute Care Studies
  • COVID-19 and Mental Health
  • HIV Research and Treatment
  • Viral Infections and Immunology Research
  • Pneumocystis jirovecii pneumonia detection and treatment
  • COVID-19 and healthcare impacts
  • Adolescent Sexual and Reproductive Health
  • Intimate Partner and Family Violence
  • Liver Disease Diagnosis and Treatment

Ministry of Public Health
2014-2024

University of Kinshasa
2021

We investigated the level of willingness for COVID-19 vaccination in Democratic Republic Congo (DRC). Data were collected between 24 August 2020 and 8 September through an online survey. A total 4131 responses included; mean age respondents was 35 years (standard deviation: 11.5); 68.4% females; 71% had elementary or secondary school education. One fourth (24.1%) convinced that did not exist. Overall, 2310 (55.9%) indicated they willing to be vaccinated. In a multivariable regression model,...

10.3390/vaccines9020153 article EN cc-by Vaccines 2021-02-14

We aimed to assess the level of adherence COVID-19 preventive measures in Democratic Republic Congo (DRC) and identify factors associated with non-adherence.A cross-sectional population-based online survey.The study was conducted 22 provinces DRC. Five a satisfactory number respondents were included analysis: Haut Katanga, Kasaï-Central, Kasaï-Oriental, Kinshasa North Kivu.The participants people aged ≥18 years, living A total 3268 analysis.Both convenience sampling (surveyors themselves...

10.1136/bmjopen-2020-043356 article EN cc-by-nc BMJ Open 2021-01-01

BackgroundHepatitis B virus (HBV) remains endemic throughout sub-Saharan Africa despite the widespread availability of effective childhood vaccines. In Democratic Republic Congo, HBV treatment and birth-dose vaccination programmes are not established. We, therefore, aimed to evaluate feasibility acceptability adding testing pregnant women as well HBV-exposed infants HIV prevention mother-to-child transmission programme infrastructure in Congo.MethodsWe did a study two maternity centres...

10.1016/s2214-109x(21)00304-1 article EN cc-by-nc-nd The Lancet Global Health 2021-08-17

<h3>Background:</h3> The immunization system in the Democratic Republic of Congo faces many challenges, including persistent large-scale outbreaks polio, measles, and yellow fever; a large number unvaccinated children for all antigens; minimal delayed funding; poor use data at levels. In response, Expanded Programme on Immunization within Ministry Health (MOH) collaborated with global partners to develop revitalization strategy routine (RI) called Mashako Plan. <h3>Mashako Plan Design...

10.9745/ghsp-d-22-00326 article EN cc-by Global Health Science and Practice 2023-04-12

Intimate Partners’ Violence (IPV) is a public health problem with long-lasting mental and physical consequences for victims their families. As evidence has been increasing that COVID-19 lockdown measures may exacerbate IPV, our study sought to describe the magnitude of IPV in women identify associated determinants. An online survey was conducted Democratic Republic Congo (DRC) from 24 August 8 September 2020. Of 4160 respondents, 2002 eligible were included data analysis. Their mean age 36.3...

10.3390/ijerph18105108 article EN International Journal of Environmental Research and Public Health 2021-05-12

Background Retaining patients with HIV infection in care is still a major challenge sub- Saharan Africa, particularly the Democratic Republic of Congo (DRC) where antiretroviral treatment (ART) coverage low. Monitoring retention an important tool for evaluating quality care. Methods and Findings A review medical records -infected children was performed three health facilities DRC: Amo-Congo Health center, Monkole Clinic Kinshasa, HEAL Africa Goma. Medical 720 were included. Kaplan Meier...

10.1371/journal.pone.0113877 article EN cc-by PLoS ONE 2014-12-26

ABSTRACT We report general acceptance of an mpox vaccine (61.0%) in the Democratic Republic Congo (n = 5226) with higher among healthcare workers and respondents historic mpox-endemic regions. These data highlight need for increased community engagement sensitization before widespread deployment vaccines.

10.1101/2024.08.15.24311971 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2024-08-16

We report general acceptance (61.0%) of an mpox vaccine in the Democratic Republic Congo among 5,226 survey respondents. Healthcare workers and respondents historic mpox-endemic regions had higher rates. These data highlight need for increased community engagement sensitization before widespread deployment vaccines.

10.3201/eid3012.241226 article EN cc-by Emerging infectious diseases 2024-11-29

Abstract Introduction The emergence of COVID-19 as a global pandemic has affected countries worldwide, including the Democratic Republic Congo (DRC). DRC experienced four waves COVID-19, each associated with new variant virus. To control spread virus, government implemented various measures, vaccination. country developed vaccine deployment plan, targeting high-risk groups, and launched vaccination campaign in April 2021. This study aims to comprehensively assess program during its first...

10.1101/2024.01.03.24300795 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2024-01-04

The WHO recommends hepatitis B birth-dose vaccination (HepB-BD), but it is not routinely given in most sub-Saharan African countries. We aimed to assess the immunogenicity of HepB-BD addition existing vaccine (HepB3) schedule Kinshasa, Democratic Republic Congo among HBV-unexposed and HBV-exposed infants. Using an open-label, randomised, controlled design, infants were randomised (1:1) receive standard HepB3 series (group U3), or U4). A supplemental cohort E4) received HepB3. compared...

10.1111/jvh.14003 article EN Journal of Viral Hepatitis 2024-09-24

Immunisation is a high priority for improving health outcomes. Yet, in many low-income and middle-income countries, achieving coverage targets independently hindered by lack of domestic resources reliance on partners’ support. Both the 2001 Abuja Declaration 2016 Addis were key political commitments to immunisation coverage; however, signatories have yet meet international targets. Despite signing Global Vaccine Action Plan Declaration, Democratic Republic Congo (DRC) was unable fully...

10.1136/bmjgh-2024-015675 article EN cc-by-nc-nd BMJ Global Health 2024-10-01

Neonatal mortality is a public health problem around the world.This observation, made on global, regional and local level, allowed us to identify in this study one of factors that seems interfere with efforts medical services improve neonatal care our living environment.It about low quality emergencies triage as noted by an inventory fixtures these two reference hospitals city Lubumbashi: The University Clinics General Hospital Sendwe.The cross-sectional descriptive type based observation...

10.4236/oalib.1108148 article EN OALib 2021-01-01

Abstract Background: Family planning (FP) is one of the main strategies to reduce maternal mortality in sub-Saharan Africa. However, only 8% women use modern contraceptive methods Democratic Republic Congo. It estimated that at least 50% stop using Modern Contraceptive Methods (MCM) The objective this study was identify factors associated with MCM discontinuation Kinshasa. Methods: A retrospective cohort conducted Kinshasa from April through June 2019. Three hundred and eighty-seven who...

10.21203/rs.3.rs-215312/v1 preprint EN cc-by Research Square (Research Square) 2021-02-26

ABSTRACT Background Hepatitis B virus (HBV) remains endemic throughout sub-Saharan Africa despite the widespread availability of effective vaccines. We evaluated feasibility adding HBV testing and treatment pregnant women birth-dose vaccination HBV-exposed infants to HIV prevention MTCT (PMTCT) program infrastructure in Democratic Republic Congo (DRC), where programs are not established. Methods As part PMTCT at two maternity centers Kinshasa, DRC, were screened for routine prenatal care...

10.1101/2021.03.19.21253929 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-03-20
Coming Soon ...